These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3362419)

  • 41. Effects of dexamethasone in hypoxic-ischemic brain injury in the neonatal rat.
    Altman DI; Young RS; Yagel SK
    Biol Neonate; 1984; 46(3):149-56. PubMed ID: 6466749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dextromethorphan does not protect against quinolinic acid neurotoxicity in rat striatum.
    Engber TM; Chase TN
    Neurosci Lett; 1988 Dec; 95(1-3):269-74. PubMed ID: 2976130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Failure of iron chelators to protect against cerebral infarction in hypoxia-ischemia.
    MacMillan V; Fridovich I; Davis J
    Can J Neurol Sci; 1993 Feb; 20(1):41-3. PubMed ID: 8467427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dragon's blood dropping pills have protective effects on focal cerebral ischemia rats model.
    Xin N; Yang FJ; Li Y; Li YJ; Dai RJ; Meng WW; Chen Y; Deng YL
    Phytomedicine; 2013 Dec; 21(1):68-74. PubMed ID: 24051215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bradykinin preconditioning induces protective effects against focal cerebral ischemia in rats.
    Ping A; Chun ZX; Xue XY
    Brain Res; 2005 Oct; 1059(2):105-12. PubMed ID: 16182259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dextromethorphan provides neuroprotection via anti-inflammatory and anti-excitotoxicity effects in the cortex following traumatic brain injury.
    Pu B; Xue Y; Wang Q; Hua C; Li X
    Mol Med Rep; 2015 Sep; 12(3):3704-3710. PubMed ID: 26004757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in Wistar rats.
    Ayoub IA; Lee EJ; Ogilvy CS; Beal MF; Maynard KI
    Neurosci Lett; 1999 Jan; 259(1):21-4. PubMed ID: 10027546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia.
    Cai Z; Lin S; Rhodes PG
    Eur J Pharmacol; 2002 Feb; 437(3):139-45. PubMed ID: 11890901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
    Slivka AP; Murphy EJ
    Exp Neurol; 2001 Jan; 167(1):166-72. PubMed ID: 11161604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dextromethorphan for treatment of complex partial seizures.
    Fisher RS; Cysyk BJ; Lesser RP; Pontecorvo MJ; Ferkany JT; Schwerdt PR; Hart J; Gordon B
    Neurology; 1990 Mar; 40(3 Pt 1):547-9. PubMed ID: 2314601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose dependence and therapeutic window for the neuroprotective effects of 17beta-estradiol when administered after cerebral ischemia.
    Liu R; Wang X; Liu Q; Yang SH; Simpkins JW
    Neurosci Lett; 2007 Mar; 415(3):237-41. PubMed ID: 17331646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tolerability of oral dextromethorphan in patients with a history of brain ischemia.
    Albers GW; Sáenz RE; Moses JA
    Clin Neuropharmacol; 1992 Dec; 15(6):509-14. PubMed ID: 1477851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cerebroprotective effect of Eclipta alba against global model of cerebral ischemia induced oxidative stress in rats.
    Mansoorali KP; Prakash T; Kotresha D; Prabhu K; Rama Rao N
    Phytomedicine; 2012 Sep; 19(12):1108-16. PubMed ID: 22951390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infarct tolerance induced by intra-cerebral infusion of recombinant brain-derived neurotrophic factor.
    Yanamoto H; Nagata I; Sakata M; Zhang Z; Tohnai N; Sakai H; Kikuchi H
    Brain Res; 2000 Mar; 859(2):240-8. PubMed ID: 10719070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postischemic infusion of Cu/Zn superoxide dismutase or SOD:Tet451 reduces cerebral infarction following focal ischemia/reperfusion in rats.
    Francis JW; Ren J; Warren L; Brown RH; Finklestein SP
    Exp Neurol; 1997 Aug; 146(2):435-43. PubMed ID: 9270054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers.
    Silvasti M; Karttunen P; Tukiainen H; Kokkonen P; Hänninen U; Nykänen S
    Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):493-7. PubMed ID: 3679620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of D-CPPene, a competitive N-methyl-D-aspartate antagonist in focal cerebral ischemia in the rat.
    Park CK; McCulloch J; Kang JK; Choi CR
    Neurosci Lett; 1992 Nov; 147(1):41-4. PubMed ID: 1480321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alteration of ischemic reperfusion injury in the rat neocortex by a potent antioxidant mexiletine.
    Chang CZ; Winardi D; Loh JK; Kung SS; Howng SL; Jeng AY; Kwan AL
    Acta Neurochir (Wien); 2002 Feb; 144(2):189-93; discussion 193. PubMed ID: 11862520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Neuroprotective activity of the proline-containing dipeptide noopept on the model of brain ischemia induced by the middle cerebral artery occlusion].
    Gavrilova SA; Us KS; Ostrovskaia RU; Koshelev VB
    Eksp Klin Farmakol; 2006; 69(4):16-8. PubMed ID: 16995431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels.
    Steinberg GK; Kunis D; Saleh J; DeLaPaz R
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):1015-24. PubMed ID: 1939379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.